Shanghai Shyndec Pharmaceutical Co., Ltd. (SHA:600420)
China flag China · Delayed Price · Currency is CNY
9.15
-0.05 (-0.54%)
May 20, 2026, 11:30 AM CST

SHA:600420 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
12,33913,54616,01413,1309,34610,650
Market Cap Growth
-9.18%-15.41%21.96%40.50%-12.25%9.04%
Enterprise Value
10,77211,51313,62310,58210,42312,754
Last Close Price
9.2010.1011.629.358.619.71
PE Ratio
17.1714.3914.7818.9814.8918.74
Forward PE
-10.4210.4210.4210.4210.42
PS Ratio
1.401.451.461.090.720.76
PB Ratio
0.770.861.050.920.771.03
P/TBV Ratio
0.951.051.291.120.971.35
P/FCF Ratio
16.199.447.869.633.679.20
P/OCF Ratio
11.987.987.107.633.276.34
PEG Ratio
-0.700.700.700.700.70
EV/Sales Ratio
1.221.231.250.880.800.92
EV/EBITDA Ratio
6.886.355.865.876.246.87
EV/EBIT Ratio
12.3210.348.7810.7612.3911.83
EV/FCF Ratio
14.138.036.697.764.0911.01
Debt / Equity Ratio
0.000.000.070.080.280.40
Debt / EBITDA Ratio
0.020.020.490.642.022.20
Debt / FCF Ratio
0.050.030.560.841.343.61
Net Debt / Equity Ratio
-0.23-0.44-0.42-0.34-0.23-0.01
Net Debt / EBITDA Ratio
-2.37-3.87-2.80-2.68-1.64-0.05
Net Debt / FCF Ratio
-4.83-4.89-3.19-3.54-1.08-0.09
Asset Turnover
0.460.480.560.620.670.75
Inventory Turnover
3.173.253.043.192.942.49
Quick Ratio
1.762.652.092.152.121.09
Current Ratio
3.593.592.692.822.791.59
Return on Equity (ROE)
5.73%7.33%8.98%7.28%7.70%8.13%
Return on Assets (ROA)
2.82%3.55%4.94%3.15%2.72%3.61%
Return on Invested Capital (ROIC)
7.06%10.86%13.49%9.14%7.54%9.56%
Return on Capital Employed (ROCE)
5.40%6.90%9.90%6.30%5.50%8.80%
Earnings Yield
5.82%6.95%6.77%5.27%6.72%5.34%
FCF Yield
6.18%10.59%12.72%10.38%27.27%10.88%
Dividend Yield
3.17%2.97%2.58%1.07%1.16%1.03%
Payout Ratio
55.18%45.44%27.75%27.37%29.42%37.39%
Buyback Yield / Dilution
-0.00%0.00%-5.31%-10.13%1.82%0.14%
Total Shareholder Return
3.17%2.97%-2.73%-9.06%2.98%1.17%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.